BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
32997133
Number of visits today
744
Number of downloads
16182932
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Sa-Nguanmoo N, Namdee K, Khongkow M, Ruktanonchai U, Zhao Y, Liang XJ. Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform. Nano Res 2021;:1-30. [PMID: 34659650 DOI: 10.1007/s12274-021-3832-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu S, Zhao Y, Guo L, Yu Q. Amoeba-inspired magnetic microgel assembly assisted by engineered dextran-binding protein for vaccination against life-threatening systemic infection. Nano Res 2023;16:938-50. [PMID: 36090612 DOI: 10.1007/s12274-022-4809-1] [Reference Citation Analysis]
2 Sarangi MK, Padhi S, Rath G, Nanda SS, Yi DK. Success of nano-vaccines against COVID-19: a transformation in nanomedicine. Expert Rev Vaccines 2022;21:1739-61. [PMID: 36384360 DOI: 10.1080/14760584.2022.2148659] [Reference Citation Analysis]
3 Tu B, Gao Y, An X, Wang H, Huang Y. Localized delivery of nanomedicine and antibodies for combating COVID-19. Acta Pharm Sin B 2022. [PMID: 36168329 DOI: 10.1016/j.apsb.2022.09.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Dri DA, Gaucci E, Torrieri I, Carafa M, Marianecci C, Gramaglia D. Critical Analysis and Quality Assessment of Nanomedicines and Nanocarriers in Clinical Trials: Three Years of Activity at the Clinical Trials Office. Pharmaceutics 2022;14:1438. [PMID: 35890333 DOI: 10.3390/pharmaceutics14071438] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345